Health
A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines – News-Medical.net
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the adv…
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the advance of such platforms in the pursuit for the effective vaccine. Their results are currently available on bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent of the ongoing COVID-19 pa…
-
Noosa News24 hours agoNew self-serve style chip shop, Chip ‘n’ Mix, in Noosa becomes an instant obsession
-
General23 hours agoPoliticians asked how to Trump-proof Australia’s fragile economy on Q+A
-
General23 hours agoAsia stocks plunge, HK suffers steepest fall since 1997
-
Noosa News15 hours agoQueensland government to review greenhouse gas emission reduction targets